Importance of prandial glucose regulation in the management of cardiovascular complications in type 2 diabetes mellitus

Romanian Journal of Diabetes, Nutrition and Metabolic Diseases

Volumn 20, Issue 1, 2013, Pages 77-84

  Strǎchinariu, Rodica Teodora ^a  

^a National Institute of Diabetes   (Romania)

Author keywords

Post prandial glucose, Cardiovascular risk factor

Indexed keywords

GLUCOSE; INSULIN SENSITIZING AGENT; METFORMIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CLINICAL TRIAL (TOPIC); DEATH; EXERCISE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; LIFE EXPECTANCY; LIFESTYLE MODIFICATION; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTPRANDIAL STATE; REVIEW; RISK FACTOR; SMOKING;

EID: 84875161353     PISSN: 15838609     EISSN: None     Source Type: Journal    
DOI: 10.2478/rjdnmd-2013-0010     Document Type: Review

References (41)

1. Burgers JS, Bailey JV, Klazinga NS, Van Der Bij AK, Grol R, Feder G; AGREE COLLABORATION. Inside guidelines: comparative analysis of recommendations and evidence in diabetes guidelines from 13 countries. Diabetes Care 25: 1933-1939, 2002.
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
3. Donahue RP, Abbott RD, Reed DM, Yano K. Post challenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program Diabetes 36: 689-692, 1987.
4. Gregg EW, Gu Q, Cheng YJ, Narayan KM, Cowie CC. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med 147: 149-155, 2007.
5. Cooper R, Cutler J, Desvigne-Nickens P et al. Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. Circulation 102: 3137-3147, 2000.
6. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes N Engl J Med 348: 383-393, 2003.
7. Tierney EF, Cadwell BL, Engelgau MM et al. Declining mortality rate among people with diabetes in North Dakota 1997-2002. Diabetes Care 27: 2723-2725, 2004.
8. Lipscombe LL, Hux JE. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet 369: 750-756, 2007.
9. Fox CS, Coady S, Sorlie PD et al. Trends in cardiovascular complications of diabetes. JAMA 292: 2495-2499, 2004.
10. Fox CS, Coady S, Sorlie PD et al. Plan and operation of the Third National Health and Nutrition Examination Survey 1988-94. Series 1: programs and collection procedures. Vital Health Stat 32: 1-407, 1994.
11. Yamagishi SI, Nakamura K, Matsui T, Ueda SI, Imaizumi T. Role of postprandial hyperglycemia in cardiovascular disease in diabetes. Int J Clin Pract 61: 83-87, 2007.
12. Bonora E. Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives. Int J Clin Pract Suppl 129: 5-11, 2002.
13. Hanefeld M, Temelkova-Kurktschiev T. Control of postprandial hyperglycemia-an essential part of good diabetes treatment and prevention of cardiovascular complications. Nutr Metab Cardiovasc Dis 12: 98-107, 2002.
14. Meigs JB, Nathan DM, D'Agostino RB, Wilson PW; Framingham Offspring Study. Fasting and post challenge glycaemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 25: 1845-1850, 2002.
15. Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30: 123-131, 1987.
16. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factors Intervention Trial. Diabetes Care 16: 434-444, 1993.
17. Peter R, Okoseime OE, Rees A, Owens DR. Postprandial glucose-a potential target to reduce cardiovascular mortality. Curr Vasc Pharmacol 7: 68-74, 2009.
18. Ceriello A. Postprandial hyperglycemia and diabetes complications: is it time to treat? Diabetes 54: 1-7, 2005.
19. Resnick HE, Shorr RI, Kuller L, Franse L, Harris TB. Prevalence and clinical implications of ADA-defined diabetes and other categories of glucose dysregulation in older adults: the health, aging and body composition study. J Clin Epidemiol 54: 869-876, 2001.
20. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 837-853, 1998.
21. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22: 233-240, 1999.
22. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 854-865, 1998.
23. Yamagishi S, Nakamura K, Matsui T, Takenaka K, Jinnouchi Y, Imaizumi T. Cardiovascular disease in diabetes. Mini Rev Med Chem 6: 313-318, 2006.
24. Da Ros R, Assaloni R, Ceriello A. Postprandial hyperglycemia and diabetic complications. Recenti Prog Med 96: 436-344, 2005.
25. Heine RJ, Balkau B, Ceriello A, Del Prato S, Horton ES, Taskinen MR. What does postprandial hyperglycaemia mean? Diabet Med 21: 208-213, 2004.
26. Woerle HJ, Neumann C, Zschau S et al. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes. Importance of postprandial glycemia to achieve target HbA1c levels. Diabetes Res Clin Pract 77: 280-285, 2007.
27. Leiter LA, Ceriello A, Davidson JA et al. Postprandial glucose regulation: new data and new implications. Clin Ther 27[Suppl B]: S42-S56, 2005.
28. Charpentier G, Riveline JP, Dardari D, Varroud-Vial M. Should postprandial hyperglycaemia in prediabetic and type 2 diabetic patients be treated? Drugs 66: 273-286, 2006.
29. Haller H. Postprandial glucose and vascular disease. Diabet Med 14[Suppl 3]: S50-S56, 1997.
30. Madsbad S, Brock B, Schmitz O. Postprandial hyperglycemia. Postprandial blood glucose fluctuations, cardiovascular diseases and late diabetic complications. Ugeskr Laeger 165: 3149-3153, 2003.
31. Chenniappan M. Insulin resistance and coronary artery disease. J Indian Med Assoc 105: 29-32, 36, 2007.
32. Furtado MV, Polanczyk CA. Cadiovascular prevention in diabetic patients: an evidenced-based review. Arq Bras Endocrinol Metabol 51: 312-318, 2007.
33. Charpentier G, Genès N, Vaur L et al. Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey. Diabetes Metab 29(2 Pt 1): 152-158, 2003.
34. Dussol B, Berland Y. What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension? Nephrol Ther 2: 51-74, 2006.
35. Standl E, Schnell O. A new look at the heart in diabetes mellitus: from ailing to failing. Diabetologia:43: 1455-1469, 2000.
36. Barr EL, Boyko EJ, Zimmet PZ, Wolfe R, Tonkin AM, Shaw JE. Continuous relationships between non-diabetic hyperglycemia and both cardiovascular disease and all cause mortality: the Australian Diabetes, Obesity, and Lifestyle (Aus-Diab) study. Diabetologia 52: 415-424, 2009.
37. Hanefeld M, Fischer S, Julius U et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11 year follow-up. Diabetologia 39: 1577-1583, 1996.
38. Cavalot F, Petrelli A, Traversa M et al. Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study. J Clin Endocr Metab 91: 813-819, 2006.
39. Haffner SM. Can reducing peaks prevent type 2 diabetes: implications from recent diabetes prevention trials. Int J Clin Pract Suppl 129: 33-39, 2002.
40. Meigs JB. Epidemiology of cardiovascular complications in type 2 diabetes mellitus. Acta Diabetol 40[Suppl 2]: S358-S361, 2003.
41. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21: 1414-1431, 1998.